SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001625101-21-000050
Filing Date
2021-10-06
Accepted
2021-10-06 09:02:58
Documents
13
Period of Report
2021-10-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K plse-20211004x8k.htm   iXBRL 8-K 87007
2 EX-99.1 plse-20211004xex99_1.htm EX-99.1 12442
  Complete submission text file 0001625101-21-000050.txt   228395

Data Files

Seq Description Document Type Size
3 EX-101.SCH plse-20211004.xsd EX-101.SCH 2771
4 EX-101.LAB plse-20211004_lab.xml EX-101.LAB 15205
5 EX-101.PRE plse-20211004_pre.xml EX-101.PRE 10926
6 EXTRACTED XBRL INSTANCE DOCUMENT plse-20211004x8k_htm.xml XML 4813
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

IRS No.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37744 | Film No.: 211308916
SIC: 3841 Surgical & Medical Instruments & Apparatus